Mr Martin Longhi Engelbrecht

Gentofte University Hospital, Gentofte (Denmark)

Follow

Contributor content

Five-year risk of death and readmission for heart failure after implantation of de novo and upgrade cardiac resynchronization therapy devices

Presentation

Five-year risk of death and readmission for heart failure after implantation of de novo and upgrade cardiac resynchronization therapy devices

ESC 365 is supported by

novartis

Explore sponsored resources